NYSE:CLDI | Income Statement | Calidi Biotherapeutics, Inc.

Complete source-backed income-statement history.

Available history
2021-06-30 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$2.56M$1.59M$4.15M-$4.15M-$5,000.00-$4.16M$5,000.00-$4.16M-$2.94-$2.941,416,0001,416,000
2026-03-31$2.59M$1.6M$4.19M-$4.19M$83,000.00-$4.1M$4,000.00-$4.11M-$0.43-$0.4310,308,00010,308,000
2025-12-31$2.36M$2.11M$4.47M-$4.47M$405,000.00-$4.06M-$2,000.00-$4.06M$0.45$0.45940940
2025-09-30$2.36M$2.69M$5.05M-$5.05M-$123,000.00-$5.17M$10,000.00-$5.15M-$2.21-$2.214,9074,907
2025-06-30$2.59M$3.07M$5.66M-$5.66M-$93,000.00-$5.76M$4,000.00-$5.72M-$31.75-$31.75180,000180,000
2025-03-31$2.43M$2.64M$5.06M-$5.06M$3,000.00-$5.06M$3,000.00-$4.99M-$2.21-$2.212,257,0002,257,000
2024-12-31$1.82M$2.21M$4.03M-$4.03M-$119,000.00-$4.15M$3,000.00-$4.1M$6.70$6.70202202
2024-09-30$2.15M$3.07M$5.23M-$5.23M$156,000.00-$5.07M-$1,000.00-$5.05M-$7.75-$7.75652652
2024-06-30$2.17M$3.61M$5.77M-$5.77M$13,000.00-$5.76M$8,000.00-$5.77M-$16.75-$16.75444444
2024-03-31$2.74M$4.01M$6.75M-$6.75M-$469,000.00-$7.22M$4,000.00-$7.23M-$2.03-$2.033,5553,555
2023-12-31$3.96M$5.86M$9.82M-$9.82M$1.59M-$8.23M-$3,000.00-$8.23M$2.47$2.47626,000626,000
2023-09-30$3.25M$3.97M$7.22M-$7.22M$5.21M-$2.01M$11,000.00-$2.02M-$1.41-$1.411,431,0001,431,000
2023-06-30$3.18M$3.36M$6.54M-$6.54M-$5.96M-$12.5M$4,000.00-$12.5M-$14.24-$14.24878,000878,000
2023-03-31$2.62M$2.79M$5.41M-$5.41M-$1.04M-$6.46M$4,000.00-$6.46M-$0.75-$0.758,655,0008,655,000
2022-12-31$0.00$2.26M$2.43M$4.69M-$4.69M-$3.07M-$7.76M-$3,000.00-$7.76M$5.07$5.0723,00023,000
2022-09-30$1.95M$5.04M$6.99M-$6.99M$1.63M-$5.35M$1,000.00-$5.36M-$0.63-$0.638,566,0008,566,000
2022-06-30$361,622.00-$361,622.00$4.52M$4.16M$0.00-$4.58M
2022-03-31$528,858.00-$528,858.00$1.99M$1.46M$0.00-$7.74M
2021-09-30$1.09M-$1.09M$271,591.00-$823,289.00$0.00-$823,289.00
2021-06-30$83,303.00-$83,303.00$0.00-$83,303.00

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$9.74M$10.5M$20.24M-$20.24M$192,000.00-$20.05M$15,000.00-$19.91M-$5.95-$5.954,3024,302
2024-12-31$8.88M$12.9M$21.78M-$21.78M-$419,000.00-$22.2M$14,000.00-$22.14M-$35.70-$35.70667667
2023-12-31$13.01M$15.98M$28.99M-$28.99M-$208,000.00-$29.2M$16,000.00-$29.22M-$17.33-$17.331,686,0001,686,000
2022-12-31$45,000.00$7.26M$15.9M$23.17M-$23.13M-$2.29M-$25.42M$11,000.00-$25.43M$2.99$2.998,505,0008,505,000